NetLicensingMar 5, 2025

The Buy vs. Build Decision: Selecting the Optimal Licensing Solution

Should you purchase a commercial #licensing system or develop one in-house? This article will help you weigh the pros and cons of each option to make an informed decision ➡️ https://netlicensing.io/blog/2025/02/28/buy-vs-build-licensing-solution/

#BuyVsBuild #Software #LicensingModels #Infrastructure #Expertise #netlicensing #LaaS

The Buy vs. Build Decision: Selecting the Optimal Licensing Solution | NetLicensing

Should you purchase a commercial licensing system or develop one in-house? This article will help you weigh the pros and cons of each option to make an informed decision

NetLicensing
tiffanyApr 25, 2023
Historically, biotech companies have been forced to build their own software tools in-house. This is an expensive, time-consuming challenge that distracts from the work that matters: developing and commercializing core IP. Thankfully, emerging vertical software tools are giving biotechs a better alternative: buy software that is extensible, and adapt it. Read more - https://blog.kaleidoscope.bio/why-biotechs-should-buy-more-of-their-software/ #biotech #biotechnology #biotechsoftware #buyvsbuild
Why biotechs should buy more of their software.

Building internal software is an expensive distraction from working on core IP. The evolution of vertical SaaS gives biotechs a better option.

Kaleidoscope